Literature DB >> 11678602

Cr (VI) increases tyrosine phosphorylation through reactive oxygen species-mediated reactions.

Y Qian1, B H Jiang, D C Flynn, S S Leonard, S Wang, Z Zhang, J Ye, F Chen, L Wang, X Shi.   

Abstract

While Cr (VI)-containing compounds are well established carcinogens, the mechanisms of their action remain to be investigated. In this study we show that Cr (VI) causes increased tyrosine phosphorylation in human lung epithelial A549 cells in a time-dependent manner. N-acetyl-cysteine (NAC), a general antioxidant, inhibited Cr (VI)-induced tyrosine phosphorylation. Catalase, a scavenger of H2O2, sodium formate and aspirin, scavengers of hydroxyl radical (*OH), also inhibited the increased tyrosine phosphorylation induced by Cr (VI). SOD, an inhibitor of superoxide radical (O2*-), caused less inhibition. ESR study shows that incubation of Cr (VI) with the A549 cells generates *OH radical. The generation of radical was decreased by addition of catalase and sodium formate, while SOD did not have any inhibitory effect. Oxygen consumption measurements show that addition of Cr (VI) to A549 cells resulted in enhanced molecular oxygen consumption. These results indicate that Cr (VI) can induce an increase in tyrosine phosphorylation. H2O2 and *OH radicals generated during the process are responsible for the increased tyrosine phosphorylation induced by Cr (VI).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11678602

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

Review 1.  Reduction of chromium(VI) and its relationship to carcinogenesis.

Authors:  X Shi; A Chiu; C T Chen; B Halliwell; V Castranova; V Vallyathan
Journal:  J Toxicol Environ Health B Crit Rev       Date:  1999 Jan-Mar       Impact factor: 6.393

Review 2.  Tyrosine-phosphorylated proteins: mediators of signal transduction from the tyrosine kinases.

Authors:  J R Glenney
Journal:  Biochim Biophys Acta       Date:  1992-03-16

Review 3.  Review of occupational epidemiology of chromium chemicals and respiratory cancer.

Authors:  R B Hayes
Journal:  Sci Total Environ       Date:  1988-06-01       Impact factor: 7.963

Review 4.  One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports.

Authors:  S Langård
Journal:  Am J Ind Med       Date:  1990       Impact factor: 2.214

Review 5.  Transcriptional regulation by extracellular signals: mechanisms and specificity.

Authors:  C S Hill; R Treisman
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

Review 6.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

7.  Reactive oxygen species activate focal adhesion kinase, paxillin and p130cas tyrosine phosphorylation in endothelial cells.

Authors:  A Gozin; E Franzini; V Andrieu; L Da Costa; E Rollet-Labelle; C Pasquier
Journal:  Free Radic Biol Med       Date:  1998-12       Impact factor: 7.376

8.  Chromium(VI)-induced nuclear factor-kappa B activation in intact cells via free radical reactions.

Authors:  J Ye; X Zhang; H A Young; Y Mao; X Shi
Journal:  Carcinogenesis       Date:  1995-10       Impact factor: 4.944

Review 9.  Mechanisms of chromium carcinogenicity and toxicity.

Authors:  M D Cohen; B Kargacin; C B Klein; M Costa
Journal:  Crit Rev Toxicol       Date:  1993       Impact factor: 5.635

10.  Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha.

Authors:  V Imbert; R A Rupec; A Livolsi; H L Pahl; E B Traenckner; C Mueller-Dieckmann; D Farahifar; B Rossi; P Auberger; P A Baeuerle; J F Peyron
Journal:  Cell       Date:  1996-09-06       Impact factor: 41.582

View more
  9 in total

1.  Time-dependent uptake, distribution and biotransformation of chromium(VI) in individual and bulk human lung cells: application of synchrotron radiation techniques.

Authors:  Hugh H Harris; Aviva Levina; Carolyn T Dillon; Irma Mulyani; Barry Lai; Zhonghou Cai; Peter A Lay
Journal:  J Biol Inorg Chem       Date:  2005-02-16       Impact factor: 3.358

2.  Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability.

Authors:  Yong Qian; Alan Ducatman; Rebecca Ward; Steve Leonard; Valerie Bukowski; Nancy Lan Guo; Xianglin Shi; Val Vallyathan; Vincent Castranova
Journal:  J Toxicol Environ Health A       Date:  2010

Review 3.  The effects of chromium(VI) on the thioredoxin system: implications for redox regulation.

Authors:  Charles R Myers
Journal:  Free Radic Biol Med       Date:  2012-04-18       Impact factor: 7.376

4.  Reduction of hexavalent chromium by human cytochrome b5: generation of hydroxyl radical and superoxide.

Authors:  Griselda R Borthiry; William E Antholine; B Kalyanaraman; Judith M Myers; Charles R Myers
Journal:  Free Radic Biol Med       Date:  2006-12-15       Impact factor: 7.376

Review 5.  Molecular mechanisms of Cr(VI)-induced carcinogenesis.

Authors:  Min Ding; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 6.  Metal-induced toxicity, carcinogenesis, mechanisms and cellular responses.

Authors:  Stephen S Leonard; Jacquelyn J Bower; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

7.  PbCrO4 mediates cellular responses via reactive oxygen species.

Authors:  Stephen S Leonard; Jenny R Roberts; James M Antonini; Vince Castranova; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

Review 8.  Metals and molecular carcinogenesis.

Authors:  Yusha Zhu; Max Costa
Journal:  Carcinogenesis       Date:  2020-09-24       Impact factor: 4.944

Review 9.  Cytogenomics of hexavalent chromium (Cr 6+) exposed cells: a comprehensive review.

Authors:  Akanksha Nigam; Shivam Priya; Preeti Bajpai; Sushil Kumar
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.